Lates News

Hong Kong's biopharmaceutical sector rose against the trend, with Fosun Pharma and Hansoh Pharmaceutical both rising over 5%, BeiGene rising over 4%, and both Sinovac Biotech and China Resources Double-Crane Pharmaceutical rising over 3%. Kangmei Pharmaceutical, Kuerle Pharmaceutical-B, and Connect Biopharmaceutical-B all rose over 2%.